U.S. Capital Wealth Advisors LLC Sells 11,902 Shares of Docusign Inc. $DOCU

Key Points

• U.S. Capital Wealth Advisors LLC reduced its stake in Docusign Inc. by 79.8% during Q2, now holding only 3,011 shares valued at approximately $235,000.
• CEO Allan C. Thygesen and CFO Blake Jeffrey Grayson notably sold a combined total of over $3.8 million in Docusign shares, indicating insider selling trends in the company.
• Docusign reported a quarterly earnings per share of $0.92, exceeding analyst estimates, with revenues rising 8.8% year-over-year to $800.64 million.

U.S. Capital Wealth Advisors LLC trimmed its position in Docusign Inc. (NASDAQ:DOCU - Free Report) by 79.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,011 shares of the company's stock after selling 11,902 shares during the period. U.S. Capital Wealth Advisors LLC's holdings in Docusign were worth $235,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Banque Transatlantique SA acquired a new position in Docusign during the 1st quarter valued at about $26,000. Hemington Wealth Management boosted its stake in Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares during the last quarter. Golden State Wealth Management LLC boosted its stake in Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after purchasing an additional 322 shares during the last quarter. Summit Securities Group LLC acquired a new position in Docusign during the 1st quarter valued at about $34,000. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in Docusign by 153.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 274 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Allan C. Thygesen sold 40,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total value of $3,100,400.00. Following the transaction, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the company's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $790,197.90. Following the completion of the transaction, the chief financial officer owned 112,160 shares in the company, valued at approximately $9,320,496. The trade was a 7.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 82,533 shares of company stock valued at $6,598,028 in the last quarter. 1.01% of the stock is currently owned by company insiders.

Docusign Stock Up 0.3%

Shares of NASDAQ DOCU opened at $81.52 on Friday. Docusign Inc. has a twelve month low of $60.60 and a twelve month high of $107.86. The stock's 50 day moving average price is $77.00 and its 200-day moving average price is $79.42. The company has a market capitalization of $16.39 billion, a PE ratio of 61.29, a PEG ratio of 4.26 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same quarter in the previous year, the business earned $0.97 EPS. The company's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, research analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has approved a stock repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its shares are undervalued.

Analyst Ratings Changes

A number of research firms have issued reports on DOCU. Royal Bank Of Canada lifted their price target on Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research note on Friday, September 5th. Morgan Stanley lifted their price target on Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday, September 8th. JMP Securities reiterated a "market outperform" rating and set a $124.00 price target on shares of Docusign in a research note on Friday, September 5th. Argus reiterated a "hold" rating on shares of Docusign in a research note on Monday, September 8th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.